vip924
vincerx pharma
['vip924', 'vincerx']
$vinc vincerx pharma presents preclinical data on vip924, a first-in-class antibody-drug conjugate (adc), at the 2023 american association for cancer research (aacr) annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities